Eastern Clinics Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 25-12-2024
- Paid Up Capital ₹ 0.17 M
as on 25-12-2024
- Company Age 48 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.80 M
as on 25-12-2024
- Revenue -16.34%
(FY 2020)
- Profit -2.97%
(FY 2020)
- Ebitda 1.55%
(FY 2020)
- Net Worth 4.19%
(FY 2020)
- Total Assets -0.45%
(FY 2020)
About Eastern Clinics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.17 M.
The company currently has active open charges totaling ₹0.80 M.
Sucharita Sengupta, Arnab Sengupta, and Sucheta Krori serve as directors at the Company.
- CIN/LLPIN
U85110WB1976PTC030564
- Company No.
030564
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 1976
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Eastern Clinics Pvt Ltd offer?
Eastern Clinics Pvt Ltd offers a wide range of products and services, including Pain Reliever Gel, Combiflam Gel, Pain Relief Drugs & Pharmaceuticals, Pain Relief Spray, Paracetamol Tablets, Crocin Tablets, Crocin Advance Tablet, Antipyretic Medication, Disprin Tablet, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Eastern Clinics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sucharita Sengupta  | Director | 03-Feb-1979 | Current |
| Arnab Sengupta | Director | 18-Apr-2006 | Current |
| Sucheta Krori | Additional Director | 03-Jul-2017 | Current |
Financial Performance of Eastern Clinics.
Eastern Clinics Pvt Ltd, for the financial year ended 2020, experienced significant reduction in revenue, with a 16.34% decrease. The company also saw a slight decrease in profitability, with a 2.97% decrease in profit. The company's net worth moved up by a moderate rise of 4.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eastern Clinics?
In 2020, Eastern Clinics had a promoter holding of 26.44% and a public holding of 73.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 13 Mar 2009 | ₹0.80 M | Open |
How Many Employees Work at Eastern Clinics?
Unlock and access historical data on people associated with Eastern Clinics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eastern Clinics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eastern Clinics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
